Thursday, August 8, 2013
Publication and contact
Escherichia coli coculture for making bispecific antibodies
An E. coli coculture
method could be used to make bispecific antibodies. Cocultures of two
different E. coli cell types expressing an anti-c-Met
proto-oncogene (MET; HGFR)
half-antibody with a 'hole' modification at the heterodimerization interface
or an anti-epidermal
growth factor receptor (EGFR)
half-antibody with a 'knob' modification at the heterodimerization interface
were harvested and lysed. In the lysate, the half-antibodies spontaneously
assembled into a bispecific antibody. In EGFR-driven, MET-driven or MET-EGFR
co-dependent xenograft mouse models, the purified bispecific antibody
decreased tumor volume compared with vehicle. The coculture method was used
to generate 27 additional bispecific antibodies. Next steps include
optimizing coculture and purification methods to increase antibody titers and
identifying new target combinations.
Published online Aug. 8, 2013
Patent and licensing status
Spiess, C. et al. Nat.
Biotechnol.; published online July 7, 2013;
Contact: Justin M. Scheer, Genentech Inc., South San
Contact: Christoph Spiess,
same affiliation as above
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]